The equity is trading flat amid the analyst chatter
Several analysts are chiming in on Nike Inc (NYSE:NKE) this morning. Cowen and Company slashed its price target to $145 from $155, while Morgan Stanley lifted its price target to $185 from $172. Cowen cited weakening demand in China, and while Morgan Stanley also noted short-term headwinds from this dwindling demand, it said its long-term revenue, margin expansion, and earnings per share (EPS) growth story still look good.
The equity remains flat amid all the analyst chatter, last seen up 0.2% at $130.25. The stock has been chopping lower on the charts since late January, when it hit an all-time high of $147.95. While the 200-day moving average briefly served as support on the charts, the equity breached this trendline earlier in the month, pressured lower by the 10-day moving average. In fact, the equity has settled lower during six of its last seven sessions, though it still sports a year-over-year lead of 31%.
Analysts are generally optimistic on NKE. Of the 20 in coverage, 18 call it a "buy" or better. Plus, the 12-month consensus price target of $164.04 is a 26% premium to current levels.
Lastly, the stock could see a short-term bounce soon, per its Relative Strength Index (RSI), which sits at 38. This indicates that the security is just on the cusp of being "oversold."